Lipohypertrophy in children and adolescents with type 1 diabetes and the associated factors
Open Access
- 12 August 2011
- journal article
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 290
Abstract
Background: Despite the important implications of lipohypertrophy for diabetes control, there is a dearth of information and research about the subject in children. The aim of this study was to study the prevalence of lipohypertrophy in children with type 1 diabetes, and to evaluate the associated factors. Findings: 119 children coming for regular follow up in the diabetes clinic were examined for the presence of lipohypertrophy by inspection and palpation. The last 4 readings of glycated hemoglobin (HbA1c) levels and other factors that may affect lipohypertrophy were documented. RESULTS: The patient's age ranged from 2 months to 21 years with a median of 10 years (inter-quartile range = 6). Lipohypertrophy occurred in 54.9% of patients, more commonly in males (62.7%) vs. females (48.4%) (P = 0.074). Grade 1 lipohypertrophy occurred in 42.5% and grade 2 in 12.4%. Lipohypertrophy was related significantly to the dose of insulin units per kg of body weight (Odds ratio [OR] = 16.4; 95% CI, 2.2 - 124.6; P = 0.007), the duration of diabetes, [OR] = 1.16; 95% CI, 1.05 - 1.32; P = 0.004)), and the body mass index (BMI) [OR] = 1.68; 95% CI, 1.25 - 2.15; P = 0.006). The mean HbA1c levels of patients with grade 1 and grade 2 lipohypertrophy did not differ from diabetics without lipohypertrophy (F = 0.178, P = 0.837) Conclusions: The presence of lipohypertrophy was significantly associated with the duration of diabetes and the body mass index. Children with lipohypertrophy needed a significantly higher dose of insulin units/kg of body weight to achieve fair control compared to children without lipohypertrophy. Further studies are needed to ascertain the clinical meaning of these findings.Keywords
This publication has 9 references indexed in Scilit:
- Lipohypertrophy: does it matter in daily life? A study using a continuous glucose monitoring systemDiabetes, Obesity and Metabolism, 2009
- Dermatological Complications of Continuous Subcutaneous Insulin Infusion in Children and AdolescentsThe Journal of Pediatrics, 2008
- The management of lipohypertrophy in diabetes careBritish Journal of Nursing, 2007
- Insulin-induced Lipohypertrophy: Report of a Case with HistopathologyEndocrine Journal, 2005
- Poor glycaemic control caused by insulin induced lipohypertrophyBMJ, 2003
- Lipohypertrophy in Young Patients With Type 1 DiabetesDiabetes Care, 2002
- Insulin antibodies are associated with lipoatrophy but also with lipohypertrophy in children and adolescents with type 1 diabetesExperimental and Clinical Endocrinology & Diabetes, 2001
- Resolution of lipohypertrophy following change of short-acting insulin to insulin lispro (Humalog®)Diabetic Medicine, 1998
- Prevalence of lipohypertrophy in insulin-treated diabetic patients and predisposing factorsExperimental and Clinical Endocrinology & Diabetes, 1996